IP Library Patent Application 12302787
Patent Application
App. No. 12/302,787

SYSTEMS AND METHODS FOR MANIPULATION OF REGENERATIVE CELLS SEPARATED AND CONCENTRATED FROM ADIPOSE TISSUE

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
12/302,787
Abstract

The invention provides methods for manipulating regenerative cells from adipose tissue. Specifically, it provides methods for enrichment of desired cells and enhancement of their therapeutic effects.

Claims (34)

1 . A method for processing regenerative cells from adipose tissue comprising:

(a) separating the regenerative cells from other sample components;

(b) concentrating the regenerative cells; and

(c) manipulating the regenerative cells;

wherein said processing results in the removal of undesired sample components or fractionation of the regenerative cells.

2 . An apparatus constructed to perform the method of claim 1 .

3 . The method of claim 1 , further comprising delivering the processed regenerative cells to a patient.

4 . A method for processing regenerative cells from adipose tissue comprising:

(a) separating the regenerative cells;

(b) concentrating the regenerative cells; and

(c) manipulating the regenerative cells;

wherein said processing results in an improvement in yield or viability of the regenerative cells.

5 . An apparatus constructed to perform the method of claim 4 .

6 . The method of claim 4 , further comprising delivering the processed regenerative cells to a patient.

7 . A method for processing regenerative cells from adipose tissue comprising:

(a) separating the regenerative cells;

(b) concentrating the regenerative cells; and

(c) manipulating the regenerative cells;

wherein said processing results in an improved therapeutic benefit of the regenerative cells.

8 . An apparatus constructed to perform the method of claim 7 .

9 . The method of claim 7 , further comprising delivering the processed regenerative cells to a patient.

10 . The method of claim 1 , wherein the manipulating step comprises physical manipulation.

11 . The method of claim 10 , wherein the physical manipulation is exposure to hypoxic or hyperoxic conditions.

12 . The method of claim 10 , wherein the physical manipulation is selected from the group comprising mechanical stimulation, ultrasonic stimulation, electrical stimulation, temperature changes, exposure to infrared light, or exposure to UV lights.

13 . The method of claim 10 , wherein the physical manipulation is separation by density gradient centrifugation or continuous flow centrifugation.

14 . The method of claim 10 , wherein the physical manipulation comprises adhering sample components to a solid phase surface, wherein said adherence selects either the regenerative cells or other sample components to be separated from the regenerative cells.

15 . The method of claim 14 , wherein the solid phase surface is selected from the group comprising tissue culture plastic, plastic beads, glass beads, scaffolds or any combinations thereof.

16 . The method of claim 4 , wherein the manipulating step comprises exposing the regenerative cells to a chemical agent or additive.

17 . The method of claim 4 , wherein the manipulating step comprises exposing the regenerative cells to a biological agent or additive.

18 . The method of claim 7 , wherein the manipulating step comprises exposing the regenerative cells to a chemical agent or additive.

19 . The method of claim 7 , wherein the manipulating step comprises exposing the regenerative cells to a biological agent or additive.

20 . The method of claim 1 , wherein the regenerative cells are delivered through scaffolds, carriers, injection, injectable solutions, beads, microspheres, nanospheres, hydrogels, gels, polymers, ceramics, collagen gels, platelet gels, hyaluronon based scaffolds, apatite coated scaffolds, self-assembled peptides, in combination with other cells or tissue or tissue fragments, timed release delivery devices or any combinations thereof.

21 . The method of claim 4 , wherein the regenerative cells are delivered through scaffolds, carriers, injection, injectable solutions, beads, microspheres, nanospheres, hydrogels, gels, polymers, ceramics, collagen gels, platelet gels, hyaluronon based scaffolds, apatite coated scaffolds, self-assembled peptides, in combination with other cells or tissue or tissue fragments, timed release delivery devices or any combinations thereof.

22 . The method of claim 7 , wherein the regenerative cells are delivered through scaffolds, carriers, injection, injectable solutions, beads, microspheres, nanospheres, hydrogels, gels, polymers, ceramics, collagen gels, platelet gels, hyaluronon based scaffolds, apatite coated scaffolds, self-assembled peptides, in combination with other cells or tissue or tissue fragments, timed release delivery devices or any combinations thereof.

Assignments (9)
CORRECTIVE ASSIGNMENT TO CORRECT THE CORRECT ASSIGNEE'S ADDRESS PREVIOUSLY RECORDED AT REEL: 049313 FRAME: 0434. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Aug 1, 2019
From: CYTORI THERAPEUTICS, INC.
To: LOREM VASCULAR PTE. LTD.
Reel/Frame 049942/0204 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 17, 2019
From: CYTORI THERAPEUTICS, INC.
To: LOREM VASCULAR PTE. LTD.
Reel/Frame 049313/0434 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 25, 2019
From: CYTORI THERAPEUTICS, INC.
To: LOREM VASCULAR PTE. LTD.
Reel/Frame 049651/0001 →
RELEASE OF SECURITY INTEREST Recorded Apr 25, 2019
From: OXFORD FINANCE LLC
To: CYTORI THERAPEUTICS, INC.
Reel/Frame 049011/0347 →
RELEASE OF SECURITY INTEREST Recorded Jun 12, 2015
From: OXFORD FINANCE LLC
To: CYTORI THERAPEUTICS, INC.
Reel/Frame 035902/0191 →
RELEASE OF SECURITY INTEREST Recorded Jul 3, 2013
From: GENERAL ELECTRIC CAPITAL CORPORATION
To: CYTORI THERAPEUTICS, INC.
Reel/Frame 030734/0778 →
SECURITY AGREEMENT Recorded Jun 28, 2013
From: CYTORI THERAPEUTICS, INC.
To: OXFORD FINANCE LLC
Reel/Frame 030715/0625 →
SECURITY AGREEMENT Recorded Dec 3, 2012
From: CYTORI THERAPEUTICS INC.
To: GENERAL ELECTRIC CAPITAL CORPORATION
Reel/Frame 029395/0660 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 12, 2009
From: HEDRICK, MARC H.; FRASER, JOHN K.
To: CYTORI THERAPEUTICS, INC.
Reel/Frame 023081/0965 →